← Back to Clinical Trials
Recruiting NCT07462000

NCT07462000 Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07462000
Status Recruiting
Phase
Sponsor Military Institute od Medicine National Research Institute
Condition Primary Open-Angle Glaucoma (POAG)
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-01-21
Primary Completion 2027-01-21

Trial Parameters

Condition Primary Open-Angle Glaucoma (POAG)
Sponsor Military Institute od Medicine National Research Institute
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-01-21
Completion 2027-01-21
Interventions
Phacoemulsification With Intraocular Lens Implantation and Deep SclerectomyPhacoemulsification With Intraocular Lens Implantation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This observational study will compare proteomic and elemental profiles of aqueous humor and ocular tissues in patients with primary open-angle glaucoma (POAG) and cataract versus cataract controls without glaucoma. Samples collected during standard surgery will be analyzed using LC-MS/MS and ICP-MS. The goal is to identify glaucoma-associated molecular patterns with potential diagnostic or prognostic relevance.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years. * Scheduled for cataract surgery (phacoemulsification with intraocular lens implantation). * Ability to provide written informed consent. * For glaucoma arm: diagnosis of primary open-angle glaucoma (POAG) with coexisting cataract, and planned combined cataract surgery with glaucoma procedure. * For control arm: cataract without glaucoma and without other significant ocular pathology. Exclusion Criteria: * Age \< 18 years. * Pregnancy or breastfeeding. * Advanced visual impairment in the study eye (visual aquity worse than counting fingers). * Any glaucoma type other than primary open-angle glaucoma (e.g., angle-closure, secondary, neovascular glaucoma). * History of intraocular surgery in the study eye (including glaucoma surgery), vitreoretinal surgery, corneal transplantation, or refractive surgery. * Active or previous uveitis. * Other significant chronic ocular disease in the study eye (other than cataract and POAG in the glaucoma arm). * Inab

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology